Comparison of inravitreal ranibizumab therapy with and without laser photocoagulation for diabetic macular edema.
Not Applicable
- Conditions
- diabetic macular edema
- Registration Number
- JPRN-UMIN000024697
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Other ocular disease. Laser photocoagulation within 3 months. Anti-VEGF therapy within 3 months. Focal steroid injection within 3 months. Diabetic retinopthy over 85 ETDRS grades. After any vitrectomy. After cataract surgery. Focal diabetic macular edema.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change from baseline in best-crrected visual acuity at 18 months.
- Secondary Outcome Measures
Name Time Method